Previous 10 | Next 10 |
Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q3 2020 Earnings Call Nov 02, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q3 2020 Earnings...
Pacific Biosciences of California, Inc. (PACB) Q3 2020 Earnings Conference Call November 02, 2020 04:30 PM ET Company Participants Trevin Rard - Investor Relations Christian Henry - Chief Executive Office Susan Kim - Chief Financial Officer Ben Gong - Vice President of Finance and Treasurer C...
Gainers: [[ANET]] +23.9%. [[JAKK]] +22.3%. [[MED]] +11.5%. [[INSP]] +10.1%. [[CDLX]] +9.5%.Losers: [[SEDG]] -19.1%. [[AUPH]] -10.3%. [[PACB]] -6.8%. [[IPI]] -5.8%. [[BRKR]] -4.6%. For further details see: ANET, JAKK, PACB and SEDG among after-hours movers
Pacific Biosciences of California (PACB): Q3 GAAP EPS of -$0.14 in-line.Revenue of $19.08M (-13.0% Y/Y) misses by $1.25M.Shares -5.66%.Press Release For further details see: Pacific Biosciences of California EPS in-line, misses on revenue
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. Third Quarter 2020 Financial Results Total revenue for the third quarter of 2020 was $...
Illumina's acquisition of Grail was received poorly - we disagree wholeheartedly with the market and see significant upside from the acquisition, which increases its addressable market by 10x. The company is dominant, with a ~70% market share, and is the global market leader in next-g...
Invitae (NVTA) will collaborate with Pacific Biosciences of California (PACB) to develop whole genome sequencing-based assays for pediatric epilepsy.The first phase of the research partnership will a whole sequencing study of a large pediatric epilepsy cohort derived from the Behind the Seizu...
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today ann...
MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time. The call will be webcast and ma...
KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, tra...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...